Impact of Chronic Spontaneous or Inducible Urticaria on Occupational Activity
DOI:
https://doi.org/10.2340/actadv.v104.36122Keywords:
chronic spontaneous urticaria, chronic inducible urticaria, occupational status, work impairment, productivity impairment, presenteismAbstract
The impact of chronic urticaria on work has been scarcely reported, whereas its peak incidence is between the ages of 20 and 40. The aim of this study was to assess the occupational impact of chronic urticaria and its treatment, by combining objective and patient-reported data. A monocentric observational study was performed using questionnaires over a 1-year period from 2021 to 2022 in chronic urticaria patients who were in a period of professional activity and agreed to participate. Of the 88 patients included, 55.7% assessed the occupational impact of their chronic urticaria as significant, and even more severe when chronic urticaria was poorly controlled. Some 86% of patients had symptoms at work, in a third of cases aggravated by work. However, occupational physical factors were not associated with an aggravation of inducible chronic urticaria. A total of 20% reported treatment-related adverse effects affecting their work. Despite low absenteeism, presenteeism and reduced productivity were important (> 20%). Six patients (6.8%) had difficulties keeping their work. For 72.7% of the patients, the occupational physician was not informed. The occupational impact of chronic urticaria should be discussed during consultations, particularly when it is insufficiently controlled. The occupational physician should be informed in order to support patients’ professional project.
Downloads
References
Fricke J, Ávila G, Keller T, Weller K, Lau S, Maurer M, et al. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy 2020; 75: 423-432.
https://doi.org/10.1111/all.14037 DOI: https://doi.org/10.1111/all.14037
Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 2022; 77: 734-766.
https://doi.org/10.1111/all.15090 DOI: https://doi.org/10.1111/all.15090
Moestrup K, Ghazanfar MN, Thomsen SF. Patient-reported outcomes (PROs) in chronic urticaria. Int J Dermatol 2017; 56: 1342-1348.
https://doi.org/10.1111/ijd.13668 DOI: https://doi.org/10.1111/ijd.13668
Maurer M, Ortonne JP, Zuberbier T. Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy 2009; 64: 581-588.
https://doi.org/10.1111/j.1398-9995.2008.01853.x DOI: https://doi.org/10.1111/j.1398-9995.2008.01853.x
Gonçalo M, Gimenéz-Arnau A, Al-Ahmad M, Ben-Shoshan M, Bernstein JA, Ensina LF, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol 2021; 184: 226-236.
https://doi.org/10.1111/bjd.19561 DOI: https://doi.org/10.1111/bjd.19561
Maurer M, Houghton K, Costa C, Dabove F, Ensina LF, Giménez-Arnau A, et al. Differences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study. World Allergy Organ J 2018; 11: 32.
https://doi.org/10.1186/s40413-018-0216-1 DOI: https://doi.org/10.1186/s40413-018-0216-1
Thomsen SF, Pritzier EC, Anderson CD, Vaugelade-Baust N, Dodge R, Dahlborn AK, et al. Chronic urticaria in the real-life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non-interventional multicentre AWARE study. J Eur Acad Dermatol Venereol 2017; 31: 1048-1055.
https://doi.org/10.1111/jdv.14210 DOI: https://doi.org/10.1111/jdv.14210
Sussman G, Abuzakouk M, Bérard F, Canonica W, Oude Elberink H, Giménez-Arnau A, et al. Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from ASSURE-CSU. Allergy 2018; 73: 1724-1734.
https://doi.org/10.1111/all.13430 DOI: https://doi.org/10.1111/all.13430
Maurer M, Abuzakouk M, Bérard F, Canonica W, Oude Elberink H, Giménez-Arnau A, et al. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU. Allergy 2017; 72: 2005-2016.
https://doi.org/10.1111/all.13209 DOI: https://doi.org/10.1111/all.13209
Maurer M, Metz M, Brehler R, Hillen U, Jakob T, Mahler V, et al. Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence. J Allergy Clin Immunol 2018; 141: 638-649.
https://doi.org/10.1016/j.jaci.2017.06.032 DOI: https://doi.org/10.1016/j.jaci.2017.06.032
Tang K, Beaton DE, Boonen A, Gignac MAM, Bombardier C. Measures of work disability and productivity: Rheumatoid Arthritis Specific Work Productivity Survey (WPS-RA), Workplace Activity Limitations Scale (WALS), Work Instability Scale for Rheumatoid Arthritis (RA-WIS), Work Limitations Questionnaire (WLQ), and Work Productivity and Activity Impairment Questionnaire (WPAI). Arthritis Care Res 2011; 63: S337-349.
https://doi.org/10.1002/acr.20633 DOI: https://doi.org/10.1002/acr.20633
Tomas H, Delaubier A. Handicap locomoteur et maintien en emploi: étude rétrospective à propos de 352 salariés reconnus travailleurs handicapés en 2013. Arch Mal Prof Enviro 2021; 82: 7-18.
https://doi.org/10.1016/j.admp.2020.04.015 DOI: https://doi.org/10.1016/j.admp.2020.04.015
Nicolas A, Launay D, Duprez C, Citerne I, Morell-Dubois S, Sobanski V, et al. Impact de l'angiœdème héréditaire sur les activités de la vie quotidienne, la sphère émotionnelle et la qualité de vie des patients. Rev Med Interne 2021; 42: 608-615.
https://doi.org/10.1016/j.revmed.2021.05.013 DOI: https://doi.org/10.1016/j.revmed.2021.05.013
Traitement de l'urticaire chronique spontanée - Document de synthèse. 2019. Available from: https://reco.sfdermato.org/fr/recommandations-urticaire-chronique-spontan%C3%A9e/bibliographie.
Magerl M, Altrichter S, Borzova E, Giménez-Arnau A, Grattan CEH, Lawlor F, et al. The definition, diagnostic testing, and management of chronic inducible urticarias: the EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy 2016; 71: 780-802.
https://doi.org/10.1111/all.12884 DOI: https://doi.org/10.1111/all.12884
UNESCO Institute for Statistics. International Standard Classification of Education ISCED 2011. 2011. Available from: http://uis.unesco.org/sites/default/files/documents/international-standard-classification-of-education-isced-2011-fr.pdf.
INSEE. Nomenclature des professions et catégories socioprofessionnelles (PCS 2020). 2020. Available from: https://www.insee.fr/fr/information/6051913.
Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dermatol 2010; 35: 869-873.
https://doi.org/10.1111/j.1365-2230.2010.03840.x DOI: https://doi.org/10.1111/j.1365-2230.2010.03840.x
Guillet G, Bécherel PA, Pralong P, Delbarre M, Outtas O, Martin L, et al. The burden of chronic urticaria: French baseline data from the international real-life AWARE study. Eur J Dermatol 2019; 29: 49-54.
https://doi.org/10.1684/ejd.2018.3495 DOI: https://doi.org/10.1684/ejd.2018.3495
Itakura A, Tani Y, Kaneko N, Hide M. Impact of chronic urticaria on quality of life and work in Japan: results of a real-world study. J Dermatol 2018; 45: 963-970.
https://doi.org/10.1111/1346-8138.14502 DOI: https://doi.org/10.1111/1346-8138.14502
Pereira ARF, Motta AA, Kalil J, Agondi RC. Chronic inducible urticaria: confirmation through challenge tests and response to treatment. Einstein Sao Paulo Braz 2020; 18: eAO5175.
https://doi.org/10.31744/einstein_journal/2020AO5175 DOI: https://doi.org/10.31744/einstein_journal/2020AO5175
Mendelson MH, Bernstein JA, Gabriel S, Balp MM, Tian H, Vietri J, et al. Patient-reported impact of chronic urticaria compared with psoriasis in the United States. J Dermatol Treat 2017; 28: 229-236.
https://doi.org/10.1080/09546634.2016.1227421 DOI: https://doi.org/10.1080/09546634.2016.1227421
Balp MM, Khalil S, Tian H, Gabriel S, Vietri J, Zuberbier T. Burden of chronic urticaria relative to psoriasis in five European countries. J Eur Acad Dermatol Venereol 2018; 32: 282-290.
https://doi.org/10.1111/jdv.14584 DOI: https://doi.org/10.1111/jdv.14584
Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCl on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol 2000; 43: 24-30.
https://doi.org/10.1067/mjd.2000.104680 DOI: https://doi.org/10.1067/mjd.2000.104680
Bérezné A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A, et al. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res 2011; 63: 277-285.
https://doi.org/10.1002/acr.20342 DOI: https://doi.org/10.1002/acr.20342
Zhang W, Bansback N, Boonen A, Young A, Singh A, Anis AH. Validity of the work productivity and activity impairment questionnaire: general health version in patients with rheumatoid arthritis. Arthritis Res Ther 2010; 12: R177.
https://doi.org/10.1186/ar3141 DOI: https://doi.org/10.1186/ar3141
Barotto F, Martin F. Services de santé au travail: qu'en pensent les salariés? Arch Prof Mal Enviro 76: 431-438.
https://doi.org/10.1016/j.admp.2014.12.014 DOI: https://doi.org/10.1016/j.admp.2014.12.014
Peres N, Morell-Dubois S, Hachulla E, Hatron PY, Duhamel A, Godard D, et al. Sclérodermie systémique et difficultés professionnelles: résultats d'une enquête prospective. Rev Med Interne 2017; 38: 718-724.
https://doi.org/10.1016/j.revmed.2017.06.006 DOI: https://doi.org/10.1016/j.revmed.2017.06.006
Maoua M, El Maalel O, Boughattas W, Kalboussi H, Ghariani N, Nouira R. Qualité de vie et activité professionnelle des patients atteints de psoriasis au centre tunisien. 2015; 76: 439-448.
https://doi.org/10.1016/j.admp.2015.02.005 DOI: https://doi.org/10.1016/j.admp.2015.02.005
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Amandine Baudy, Nadia Raison-Peyron, Chris Serrand, Marie-Noëlle Crépy, Aurélie Du-Thanh
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
